Many of the top large-cap device makers reported relatively rosy fourth-quarter earnings while issuing 2023 guidance that was above analyst expectations.

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...

Analyst Nico Chen of DBS maintained a Hold rating on Medtronic (MDT – Research Report), retaining the price target of $90.00. Nico Chen ...

Medtronic (MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened ...

Medtronic announced results from a survey indicating that AI and VR could help reduce disparities in access to surgical ...

医疗器械制造商美敦力（Medtronic）的高管表示，该公司非常看好生成式人工智能的应用前景，因此公司要求每个部门研究如何利用这项技术提高生产率，或者改善患者的治疗效果。

Medtronic in Santa Ana says its layoffs are temporary while it repairs a roof, while Avante in San Clemente wades through ...

Medtronic is a compelling investment with its diverse revenue streams, strong growth, and promising product pipeline at an ...

Medtronic (NYSE:MDT – Free Report) had its price target increased by Truist Financial from $90.00 to $93.00 in a report issued on Monday, Benzinga reports. The firm currently has a hold rating on the ...

The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in patients with ventricular tachycardia, an abnormal heart rhythm.

Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or ...

Wedmont Private Capital raised its holdings in shares of Medtronic plc (NYSE:MDT – Free Report) by 10.5% in the third quarter ...